Mitiglinide

Revision as of 14:12, 20 August 2008 by NNethala (talk | contribs)
Jump to: navigation, search

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Mitiglinide
Mitiglinide.svg
Clinical data
Routes of
administration
oral
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H25NO3
Molar mass315.41 g/mol

WikiDoc Resources for Mitiglinide

Articles

Most recent articles on Mitiglinide

Most cited articles on Mitiglinide

Review articles on Mitiglinide

Articles on Mitiglinide in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Mitiglinide

Images of Mitiglinide

Photos of Mitiglinide

Podcasts & MP3s on Mitiglinide

Videos on Mitiglinide

Evidence Based Medicine

Cochrane Collaboration on Mitiglinide

Bandolier on Mitiglinide

TRIP on Mitiglinide

Clinical Trials

Ongoing Trials on Mitiglinide at Clinical Trials.gov

Trial results on Mitiglinide

Clinical Trials on Mitiglinide at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Mitiglinide

NICE Guidance on Mitiglinide

NHS PRODIGY Guidance

FDA on Mitiglinide

CDC on Mitiglinide

Books

Books on Mitiglinide

News

Mitiglinide in the news

Be alerted to news on Mitiglinide

News trends on Mitiglinide

Commentary

Blogs on Mitiglinide

Definitions

Definitions of Mitiglinide

Patient Resources / Community

Patient resources on Mitiglinide

Discussion groups on Mitiglinide

Patient Handouts on Mitiglinide

Directions to Hospitals Treating Mitiglinide

Risk calculators and risk factors for Mitiglinide

Healthcare Provider Resources

Symptoms of Mitiglinide

Causes & Risk Factors for Mitiglinide

Diagnostic studies for Mitiglinide

Treatment of Mitiglinide

Continuing Medical Education (CME)

CME Programs on Mitiglinide

International

Mitiglinide en Espanol

Mitiglinide en Francais

Business

Mitiglinide in the Marketplace

Patents on Mitiglinide

Experimental / Informatics

List of terms related to Mitiglinide

Mitiglinide (trade name Glufast®) is a drug for the treatment of type 2 diabetes.

Mitiglinide belongs to the meglitinide class of blood glucose-lowering drugs and is currently co-marketed in Japan by Kissei and Takeda. The North America rights to mitiglinide are held by Elixir Pharmaceuticals. Mitiglinide has not yet gained FDA approval.

Pharmacology

Mitiglinide is thought to stimulate insulin secretion by closing the ATP-sensitive K(+) (K(ATP)) channels in pancreatic beta-cells.

Dosage

Mitiglinide is delivered in tablet form.

External links

Cost Effectiveness of Mitiglinide

| group5 = Clinical Trials Involving Mitiglinide | list5 = Ongoing Trials on Mitiglinide at Clinical Trials.govTrial results on MitiglinideClinical Trials on Mitiglinide at Google


| group6 = Guidelines / Policies / Government Resources (FDA/CDC) Regarding Mitiglinide | list6 = US National Guidelines Clearinghouse on MitiglinideNICE Guidance on MitiglinideNHS PRODIGY GuidanceFDA on MitiglinideCDC on Mitiglinide


| group7 = Textbook Information on Mitiglinide | list7 = Books and Textbook Information on Mitiglinide


| group8 = Pharmacology Resources on Mitiglinide | list8 = AND (Dose)}} Dosing of MitiglinideAND (drug interactions)}} Drug interactions with MitiglinideAND (side effects)}} Side effects of MitiglinideAND (Allergy)}} Allergic reactions to MitiglinideAND (overdose)}} Overdose information on MitiglinideAND (carcinogenicity)}} Carcinogenicity information on MitiglinideAND (pregnancy)}} Mitiglinide in pregnancyAND (pharmacokinetics)}} Pharmacokinetics of Mitiglinide


| group9 = Genetics, Pharmacogenomics, and Proteinomics of Mitiglinide | list9 = AND (pharmacogenomics)}} Genetics of MitiglinideAND (pharmacogenomics)}} Pharmacogenomics of MitiglinideAND (proteomics)}} Proteomics of Mitiglinide


| group10 = Newstories on Mitiglinide | list10 = Mitiglinide in the newsBe alerted to news on MitiglinideNews trends on Mitiglinide


| group11 = Commentary on Mitiglinide | list11 = Blogs on Mitiglinide

| group12 = Patient Resources on Mitiglinide | list12 = Patient resources on MitiglinideDiscussion groups on MitiglinidePatient Handouts on MitiglinideDirections to Hospitals Treating MitiglinideRisk calculators and risk factors for Mitiglinide


| group13 = Healthcare Provider Resources on Mitiglinide | list13 = Symptoms of MitiglinideCauses & Risk Factors for MitiglinideDiagnostic studies for MitiglinideTreatment of Mitiglinide

| group14 = Continuing Medical Education (CME) Programs on Mitiglinide | list14 = CME Programs on Mitiglinide

| group15 = International Resources on Mitiglinide | list15 = Mitiglinide en EspanolMitiglinide en Francais

| group16 = Business Resources on Mitiglinide | list16 = Mitiglinide in the MarketplacePatents on Mitiglinide

| group17 = Informatics Resources on Mitiglinide | list17 = List of terms related to Mitiglinide


}}



Linked-in.jpg